Skip to main content
. 2019 Dec 30;15(4):397–415. doi: 10.1016/j.ajps.2019.11.004

Fig. 8.

Fig 8

Fabrication of Escherichia coli (E. coli) generating OMV and assessment of in vitro and in vivo efficacy. (A) E. coli generating OMV displaying HER2-specific affibody and loaded siRNA for cancer therapy. (B) In vitro cell viability evaluation among different groups. (C) Excised tumor tissues of different groups after therapy. Reproduced with permission from [120]. Copyright 2014 American Chemical Society.